On 30 May 2016
Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2016, to consider and approve the Quarterly / Yearly Audited Financial Results for the aforesaid Quarter / Year end and to consider recommendation of Dividend, if any on the Equity Shares of the Company.Powered by Capital Market - Live News